Previous data from our laboratory demonstrate that DIO mice with mammary carcinoma display reduced immunotherapeutic efficacy, in part due to CXCL1-driven accumulation of FASL+ MDSCs inducing apoptosis in effector CD8+ TILs [10]. This evidence concerns the gene FASLG and breast carcinoma.